Vaxil Bio Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$254 over the previous period. Total operating expenses were $254,000.
Profit Margin
| 2012 | 0 | -519.44K | |
|---|---|---|---|
| 2014 | 0 | -1.85K | |
| 2015 | 0 | -1.07M | |
| 2016 | 0 | -4.53M | |
| 2018 | 0 | -1.04M | |
| 2019 | 0 | -1.16M | |
| 2020 | 0 | -1.36M | |
| 2021 | 0 | -986K | |
| 2022 | 0 | -584K | |
| 2023 | 0 | -254 |
VXL.V Income Statement (2012 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 2K | 25K | 57K | 100K | 56K | 22K | 9K | 11 | 241.87K |
Gross profit | 0 | -2K | -25K | -57K | -100K | -56K | -22K | -9K | -11 | -241.87K |
Operating exp. | ||||||||||
Research and development | 114K | 343K | 539K | 619K | 750K | 575K | 585K | 345K | 681 | 0 |
Selling and marketing | 40K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 8.21K |
Total operating expenses | 254K | 584K | 986K | 1.34M | 1.14M | 1.04M | 4.48M | 1.07M | 1.77K | 278.14K |
Operating income | -254K | -584K | -986K | -1.34M | -1.14M | -1.04M | -4.54M | -1.07M | -1.67K | -520.01K |
Other income (expenses), net | 0 | 0 | 0 | -11K | -11K | -6K | -60K | -3K | -178 | 566 |
Income before tax | -254K | -584K | -986K | -1.35M | -1.15M | -1.04M | -4.53M | -1.07M | -1.85K | -519.44K |
Income tax expense | 0 | 0 | 0 | 11K | 11K | 6K | 100K | 3K | 0 | 0 |
Net income | -254 | -584K | -986K | -1.36M | -1.16M | -1.04M | -4.53M | -1.07M | -1.85K | -519.44K |
Earnings per share | ||||||||||
Basic EPS | 0 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.12 | -0.08 | -0.13 | -0.56 |
Diluted EPS | 0 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.12 | -0.08 | -0.13 | -0.56 |